Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elasy, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Elasy, T.
Related Collections
Right arrowRelated Articles
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 25:1-2, 2007
© American Diabetes Association ®, Inc., 2007


Editorial

Diabetes and C-Reactive Protein

Tom Elasy, MD, MPH, Editor-in-Chief

The first 20% of the full text of this article appears below.

Since Celsus (~ 50 BC), who is credited with describing rubor, calor, dolor, and tumor as key attributes of inflammation, pathology has been a foundational study of physicians. The study of the structural and functional processes that underlie disease has always engaged physicians in much the same way that disturbances in economies would attract economists. And, like other professionals, our observations about processes beget inferences that occasionally beget predictions that occasionally beget recommendations.

In this issue, we see several attempts to understand or respond to the processes that underlie dysfunction. At a forest level, Robb Malone, PharmD, CDE, CPP; Betsy Bryant Shilliday, PharmD, CDE, CPP; Timothy J. Ives, PharmD, MPH; and Michael Pignone, MD, MPH (p. 31) describe an attempt to improve care at a large hospital in North Carolina based on perceived dysfunctions in the system that delivers care. With this elegant and detailed description of an attempt to improve . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles:

C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge
David M. Capuzzi and Jeffrey S. Freeman
Clin. Diabetes 2007 25: 16-22. [Abstract] [Full Text] [PDF]

Diabetes: Magnitude and Mechanisms
Michael J. Fowler
Clin. Diabetes 2007 25: 25-28. [Extract] [Full Text] [PDF]

Development and Evolution of a Primary Care-Based Diabetes Disease Management Program
Robb Malone, Betsy Bryant Shilliday, Timothy J. Ives, and Michael Pignone
Clin. Diabetes 2007 25: 31-35. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.